| Q2 2024 |
166 |
$6.15B |
+$428M |
-$706M |
-$279M |
IONS, ARGX, VRTX, NBIX, ISRG
|
13F-HR |
8/14/2024, 02:04 PM |
| Q1 2024 |
169 |
$6.56B |
+$354M |
-$588M |
-$233M |
IONS, ARGX, NBIX, VRTX, ISRG
|
13F-HR |
5/15/2024, 02:57 PM |
| Q4 2023 |
161 |
$6.54B |
+$441M |
-$807M |
-$366M |
IONS, ARGX, NBIX, VRTX, ISRG
|
13F-HR |
2/14/2024, 12:10 PM |
| Q3 2023 |
154 |
$6.21B |
+$219M |
-$379M |
-$160M |
ARGX, IONS, VRTX, NBIX, ISRG
|
13F-HR |
11/14/2023, 01:54 PM |
| Q2 2023 |
156 |
$7.01B |
+$379M |
-$604M |
-$225M |
VRTX, IONS, ARGX, ISRG, NBIX
|
13F-HR |
8/14/2023, 12:53 PM |
| Q1 2023 |
159 |
$6.89B |
+$210M |
-$577M |
-$367M |
VRTX, IONS, ARGX, NBIX, ISRG
|
13F-HR |
5/15/2023, 10:12 AM |
| Q4 2022 |
171 |
$7.53B |
+$333M |
-$343M |
-$10.9M |
IONS, ARGX, NBIX, VRTX, MRNA
|
13F-HR |
2/14/2023, 12:44 PM |
| Q3 2022 |
176 |
$6.97B |
+$136M |
-$413M |
-$277M |
IONS, VRTX, ARGX, NBIX, ALNY
|
13F-HR |
11/14/2022, 01:52 PM |
| Q2 2022 |
172 |
$7.07B |
+$415M |
-$594M |
-$179M |
IONS, ARGX, VRTX, NBIX, MRNA
|
13F-HR |
8/11/2022, 10:51 AM |
| Q1 2022 |
177 |
$8.61B |
+$494M |
-$873M |
-$378M |
VRTX, IONS, ARGX, NBIX, MRNA
|
13F-HR |
5/13/2022, 04:19 PM |
| Q4 2021 |
191 |
$9.7B |
+$843M |
-$442M |
+$400M |
MRNA, VRTX, ARGX, IONS, NBIX
|
13F-HR |
2/10/2022, 10:50 AM |
| Q3 2021 |
219 |
$9.85B |
+$689M |
-$821M |
-$133M |
MRNA, VRTX, IONS, ARGX, NBIX
|
13F-HR |
11/12/2021, 06:30 AM |
| Q2 2021 |
213 |
$10.2B |
+$934M |
-$737M |
+$197M |
MRNA, IONS, VRTX, NBIX, ARGX
|
13F-HR |
8/12/2021, 12:51 PM |
| Q1 2021 |
216 |
$9.45B |
+$1.07B |
-$461M |
+$609M |
IONS, MRNA, NBIX, VRTX, ARGX
|
13F-HR |
5/11/2021, 05:46 PM |
| Q4 2020 |
222 |
$8.73B |
+$1.08B |
-$848M |
+$236M |
IONS, NBIX, MRNA, VRTX, ARGX
|
13F-HR |
2/16/2021, 08:59 AM |
| Q3 2020 |
217 |
$7.24B |
+$486M |
-$290M |
+$197M |
IONS, NBIX, INCY, VRTX, ARGX
|
13F-HR |
11/16/2020, 04:23 PM |
| Q2 2020 |
208 |
$7.07B |
+$580M |
-$520M |
+$60.6M |
IONS, NBIX, INCY, VRTX, ESPR
|
13F-HR |
8/13/2020, 04:04 PM |
| Q1 2020 |
214 |
$5.16B |
+$382M |
-$411M |
-$29M |
IONS, VRTX, NBIX, INCY, ALNY
|
13F-HR |
5/14/2020, 02:32 PM |
| Q4 2019 |
215 |
$6.31B |
+$583M |
-$591M |
-$8.48M |
IONS, NBIX, INCY, VRTX, ESPR
|
13F-HR |
2/14/2020, 02:38 PM |
| Q3 2019 |
210 |
$5.38B |
+$344M |
-$242M |
+$102M |
IONS, NBIX, INCY, VRTX, SAGE
|
13F-HR |
11/14/2019, 04:57 PM |
| Q2 2019 |
201 |
$5.86B |
+$4.19B |
-$162M |
+$4.03B |
IONS, INCY, NBIX, VRTX, SAGE
|
13F-HR |
8/14/2019, 02:28 PM |
| Q1 2019 |
134 |
$1.82B |
+$303M |
-$229M |
+$73.4M |
ALGN, ISRG, ABT, ILMN, TDOC
|
13F-HR |
5/15/2019, 03:12 PM |
| Q4 2018 |
138 |
$1.52B |
+$368M |
-$150M |
+$218M |
ILMN, ABT, ISRG, ALGN, ELV
|
13F-HR |
2/12/2019, 05:17 PM |
| Q3 2018 |
138 |
$1.58B |
+$287M |
-$53.9M |
+$233M |
ELV, ALGN, ABT, CELG, ILMN
|
13F-HR |
11/13/2018, 12:32 PM |
| Q2 2018 |
138 |
$1.17B |
+$196M |
-$117M |
+$78.5M |
ELV, ALGN, CELG, ISRG, ILMN
|
13F-HR |
8/7/2018, 05:03 PM |
| Q1 2018 |
124 |
$1.01B |
+$145M |
-$122M |
+$23.9M |
ALGN, ELV, CELG, ISRG, ABT
|
13F-HR |
5/9/2018, 02:42 PM |
| Q4 2017 |
134 |
$957M |
+$147M |
-$131M |
+$15.9M |
CELG, ELV, ALGN, ISRG, ILMN
|
13F-HR |
2/14/2018, 03:48 PM |
| Q3 2017 |
131 |
$956M |
+$159M |
-$73M |
+$86.3M |
CELG, AMGN, ALGN, GILD, ILMN
|
13F-HR |
11/13/2017, 12:20 PM |
| Q2 2017 |
132 |
$844M |
+$126M |
-$85.5M |
+$40.5M |
CELG, AMGN, MDT, UNH, ELV
|
13F-HR |
8/14/2017, 01:23 PM |
| Q1 2017 |
132 |
$750M |
+$243M |
-$34.1M |
+$209M |
CELG, AMGN, INCY, CNC, UNH
|
13F-HR |
5/11/2017, 02:37 PM |
| Q4 2016 |
122 |
$488M |
+$45.6M |
-$65M |
-$19.4M |
CELG, SYK, MDT, UNH, ABT
|
13F-HR |
2/10/2017, 12:48 PM |
| Q3 2016 |
121 |
$552M |
+$49.5M |
-$54.2M |
-$4.62M |
MDT, SYK, CELG, ILMN, BIIB
|
13F-HR |
11/10/2016, 04:19 PM |
| Q2 2016 |
124 |
$531M |
+$85.7M |
-$118M |
-$32M |
MDT, SYK, CELG, ABT, CAH
|
13F-HR |
8/12/2016, 04:58 PM |
| Q1 2016 |
130 |
$551M |
$0 |
$0 |
|
GILD, CELG, MDT, BIIB, ABT
|
13F-HR |
5/16/2016, 10:21 AM |